Fenwal is a global blood technology company dedicated to supporting transfusion medicine and cell therapies.  We help ensure the availability, safety, and effectiveness of treatments that depend on blood – medicine’s most vital natural resource. Fenwal is a Fresenius Kabi company.

News

Fresenius Kabi Begins Clinical Trial of the Amicus
Red Blood Cell Exchange System